Back to Search
Start Over
Cost-effectiveness of consolidation durvalumab after chemo-radiotherapy in stage III non-small-cell lung cancer: A cost-effective change.
- Source :
-
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2022 Mar; Vol. 28 (2), pp. 438-441. Date of Electronic Publication: 2021 Oct 05. - Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 1477-092X
- Volume :
- 28
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publication Type :
- Academic Journal
- Accession number :
- 34609930
- Full Text :
- https://doi.org/10.1177/10781552211045362